PLIANT THERAPEUTICS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

PLIANT THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $45.45 million for the year ending 2025.

  • PLIANT THERAPEUTICS, INC. showed a decrease of -36.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from PLIANT THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), PLIANT THERAPEUTICS, INC.'s Cash And Cash Equivalents At Carrying Value has declined by 47.0%.
  • Historical annual values: Fiscal year 2025: $45.45 million | Fiscal year 2024: $71.19 million | Fiscal year 2023: $63.23 million | Fiscal year 2022: $33.69 million | Fiscal year 2021: $51.67 million | Fiscal year 2020: $50.88 million | Fiscal year 2019: $85.81 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: